When mice received FMT from donor responders, they exhibited decreased tumour size, increased accumulation of CD4+CXCR3+ tumour infiltrating lymphocytes (TILs), and increased expression of PD-L1 on splenic CD4+ cells [63]. The gene discussed is CXCR3; the disease is neoplasm.